日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Cupriavidus pinatubonensis Threonine--tRNA ligase (thrS), partial CSB-YP670626DZR
CSB-EP670626DZR
CSB-BP670626DZR
CSB-MP670626DZR
CSB-EP670626DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant F17g-G fimbrial adhesin (f17gG) CSB-YP670627ENL
CSB-EP670627ENL
CSB-BP670627ENL
CSB-MP670627ENL
CSB-EP670627ENL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Lipoprotein-releasing system ATP-binding protein LolD (lolD) CSB-YP670628DZR
CSB-EP670628DZR
CSB-BP670628DZR
CSB-MP670628DZR
CSB-EP670628DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Urease subunit alpha (ureC), partial CSB-YP670629DZR
CSB-EP670629DZR
CSB-BP670629DZR
CSB-MP670629DZR
CSB-EP670629DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis NADH-quinone oxidoreductase subunit C (nuoC) CSB-YP670630DZR
CSB-EP670630DZR
CSB-BP670630DZR
CSB-MP670630DZR
CSB-EP670630DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis 2-isopropylmalate synthase (leuA), partial CSB-YP670631DZR
CSB-EP670631DZR
CSB-BP670631DZR
CSB-MP670631DZR
CSB-EP670631DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Type II secretion system protein M (outM), partial CSB-YP670632EGI
CSB-EP670632EGI
CSB-BP670632EGI
CSB-MP670632EGI
CSB-EP670632EGI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Outer membrane pore protein E (phoE) CSB-YP670633EKS
CSB-EP670633EKS
CSB-BP670633EKS
CSB-MP670633EKS
CSB-EP670633EKS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Valine--tRNA ligase (valS), partial CSB-YP670634DZR
CSB-EP670634DZR
CSB-BP670634DZR
CSB-MP670634DZR
CSB-EP670634DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis N utilization substance protein B homolog (nusB) CSB-YP670635DZR
CSB-EP670635DZR
CSB-BP670635DZR
CSB-MP670635DZR
CSB-EP670635DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis UPF0301 protein Reut_A0705 (Reut_A0705) CSB-YP670636DZR
CSB-EP670636DZR
CSB-BP670636DZR
CSB-MP670636DZR
CSB-EP670636DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Colicin-K (cka), partial CSB-YP670637ENL1
CSB-EP670637ENL1
CSB-BP670637ENL1
CSB-MP670637ENL1
CSB-EP670637ENL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pectobacterium carotovorum subsp. carotovorum HTH-type transcriptional regulator rdgA (rdgA) CSB-YP670638ESP
CSB-EP670638ESP
CSB-BP670638ESP
CSB-MP670638ESP
CSB-EP670638ESP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Adenylate kinase (adk) CSB-YP670639DZR
CSB-EP670639DZR
CSB-BP670639DZR
CSB-MP670639DZR
CSB-EP670639DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP670640DZR
CSB-EP670640DZR
CSB-BP670640DZR
CSB-MP670640DZR
CSB-EP670640DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP670641DZR
CSB-EP670641DZR
CSB-BP670641DZR
CSB-MP670641DZR
CSB-EP670641DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Putative pterin-4-alpha-carbinolamine dehydratase 1 (Reut_A0417) CSB-YP670642DZR
CSB-EP670642DZR
CSB-BP670642DZR
CSB-MP670642DZR
CSB-EP670642DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Antitoxin YafW (yafW) CSB-YP670643ENV
CSB-EP670643ENV
CSB-BP670643ENV
CSB-MP670643ENV
CSB-EP670643ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis HPr kinase/phosphorylase (hprK) CSB-YP670644DZR
CSB-EP670644DZR
CSB-BP670644DZR
CSB-MP670644DZR
CSB-EP670644DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus pinatubonensis Protoheme IX farnesyltransferase (ctaB), partial CSB-YP670645DZR
CSB-EP670645DZR
CSB-BP670645DZR
CSB-MP670645DZR
CSB-EP670645DZR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×